Dehydroepiandrosterone effects on Akt signaling modulation in central nervous system of young and aged healthy rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 4, 2010, Pages 142-148

  Janner, Daiane da Rocha ^a   Jacob, Maria H V M ^a   Jahn, Matheus P ^a   Kucharski, Luiz Carlos R ^a   Ribeiro, Maria Flávia Marques ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aging; Akt; DHEA; Nervous system

Indexed keywords

PRASTERONE; PROTEIN KINASE B; IMMUNOLOGICAL ADJUVANT;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ADJUVANTS, IMMUNOLOGIC; AGING; ANIMALS; DEHYDROEPIANDROSTERONE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77957262128     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.07.006     Document Type: Article

References (62)

1. Dickstein D.L., Kabaso D., Rocher A.B., Luebke J.I., Wearne S.L., Hof P.R. Changes in the structural complexity of the aged brain. Aging Cell 2007, 6(3):275-284.
2. Chahal H.S., Drake W.M. The endocrine system and ageing. J. Pathol. 2007, 211(2):173-180.
3. Genazzani A.D., Lanzoni C., Genazzani A.R. Might DHEA be considered a beneficial replacement therapy in the elderly?. Drugs Aging 2007, 24(3):173-185.
4. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 2009, 30(1):65-91.
5. Mellon S.H. Neurosteroid regulation of central nervous system development. Pharmacol. Ther. 2007, 116(1):107-124.
6. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 2002, 87(11):5138-5143.
7. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., De Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4279-4284.
8. Schmidt P.J., Daly R.C., Bloch M., Smith M.J., Danaceau M.A., St Clair L.S., Murphy J.H., Haq N., Rubinow D.R. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch. Gen. Psychiatry 2005, 62:154-162.
9. Kimonides V.G., Spillantini M.G., Sofroniew M.V., Fawcett J.W., Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 1999, 89:429-436.
10. Kurata K., Takebayashi M., Morinobu S., Yamawaki S. beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-d-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms. J. Pharmacol. Exp. Ther. 2004, 311(1):237-245.
11. Xilouri M., Papazafiri P. Induction of Akt by endogenous neurosteroids and calcium sequestration in P19 derived neurons. Neurotox. Res. 2008, 13(3-4):209-219.
12. Leskiewicz M., Regulska M., Budziszewska B., Jantas D., Jaworska-Feil L., Basta-Kaim A., Kubera M., Jagla G., Nowak W., Lason W. Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 2008, 86(6):1361-1370.
13. Li Z., Cui S., Zhang Z., Zhou R., Ge Y., Sokabe M., Chen L. DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2009, 29(2):287-296.
14. Aragno M., Tamagno E., Gatto V., Brignardello E., Parola S., Danni O., Boccuzzi G. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic. Biol. Med. 1999, 26:1467-1474.
15. Aragno M., Mastrocola R., Brignardello E., Catalano M., Robino G., Manti R., Parola M., Danni O., Boccuzzi G. Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. Endocrinology 2002, 143(9):3250-3258.
16. Webb S.J., Geoghegan T.E., Prough R.A., Michael Miller K.K. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab. Rev. 2006, 38(1-2):89-116.
17. Chen L., Miyamoto Y., Furuya K., Dai X.N., Mori N., Sokabe M. Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology 2006, 51(3):659-670.
18. Xilouri M., Papazafiri P. Anti-apoptotic effects of allopregnanolone on P19 neurons. Eur. J. Neurosci. 2006, 23(1):43-54.
19. Cheng Z.X., Lan D.M., Wu P.Y., Zhu Y.H., Dong Y., Ma L., Zheng P. Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors. Exp. Neurol. 2008, 210(1):128-136.
20. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., Gravanis A. G-protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 2006, 20(3):577-579.
21. Charalampopoulos I., Margioris A.N., Gravanis A. Neurosteroid dehydroepiandrosterone exerts anti-apoptotic effects by membrane-mediated, integrated genomic and non-genomic pro-survival signaling pathways. J. Neurochem. 2008, 107(5):1457-1469.
22. Zhang L., Li B., Ma W., Barker J.L., Chang Y.H., Zhao W., Rubinow D.R. Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Mol. Brain Res. 2002, 98:58-66.
23. Sale E.M., Sale G.J. Protein kinase B: signalling roles and therapeutic targeting. Cell. Mol. Life Sci. 2008, 65(1):113-127.
24. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., Spencer J.P. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103(4):1355-1367.
25. Cole G.M., Frautschy S.A. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp. Gerontol. 2007, 42(1-2):10-21.
26. Cao J.J., Kurimoto P., Boudignon B., Rosen C., Lima F., Halloran B.P. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J. Bone Miner. Res. 2007, 22(8):1271-1279.
27. Garcia-Segura L.M., Diz-Chaves Y., Perez-Martin M., Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 2007, 32(Suppl 1):S57-S61.
28. Nie K., Yu J.C., Fu Y., Cheng H.Y., Chen F.Y., Qu Y., Han J.X. Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem. Biophys. Res. Commun. 2009, 378(1):103-107.
29. Rickle A., Bogdanovic N., Volkman I., Winblad B., Ravid R., Cowburn R.F. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 2004, 15(6):955-959.
30. Burke R.E. Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol. Ther. 2007, 114(3):261-277.
31. Legrain S., Girard L. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging 2003, 20(13):949-967.
32. Jacob M.H.V.M., Janner D.R., Belló-Klein A., Llesuy S.F., Ribeiro M.F.M. Dehydroepiandrosterone modulates antioxidant enzymes and Akt signaling in healthy Wistar rat hearts. J. Steroid Biochem. Mol. Biol. 2008, 112(1-3):138-144.
33. Medina M.C., Souza L.C., Caperuto L.C., Anhê G.F., Amanso A.M., Teixeira V.P.A., Bordin S., Carpinelli A.R., Britto L.R., Barbieri R.L., Borella M.I., Carvalho C.R. DHEA increases β-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Lett. 2006, 580:285-290.
34. Campbell C.S., Caperuto L.C., Hirata A.E., Araujo E.P., Velloso L.A., Saad M.J., Carvalho C.R. The phosphatidylinositol/Akt/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sci. 2004, 76(1):57-70.
35. Jacob M.H.V.M., Janner D.R., Jahn M.P., Kucharski L.C.R., Belló-Klein A., Ribeiro M.F.M. DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats. Steroids 2009, 74(13-14):1045-1050.
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochemi. 1976, 72:248-254.
37. Laurine E., Lafitte D., Grégoire C., Sérée E., Loret E., Douillard S., Michel B., Briand C., Verdier J.M. Specific binding of DHEA to the N terminus of the microtubule-associated protein MAP2. J. Biol. Chem. 2003, 278(32):29979-29986.
38. Smith R.G., Betancourt L., Sun Y. Molecular endocrinology and physiology of the aging central nervous system. Endocr. Rev. 2005, 26(2):203-250.
39. Chadashvili T., Peterson D.A. Cytoarchitecture of fibroblast growth factor receptor 2 (FGFR-2) immunoreactivity in astrocytes of neurogenic and non-neurogenic regions of the young adult and aged rat brain. J. Comp. Neurol. 2006, 498(1):1-15.
40. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res. Rev. 2005, 4(2):195-212.
41. Williams B., Granholm A.C., Sambamurti K. Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci. Lett. 2007, 413(2):110-114.
42. Read D.E., Gorman A.M. Involvement of Akt in neurite outgrowth. Cell. Mol. Life Sci. 2009, 66(18):2975-2984.
43. Eto R., Abe M., Hayakawa N., Kato H., Araki T. Age-related changes of calcineurin and Akt1/protein kinase Balpha (Akt1/PKBalpha) immunoreactivity in the mouse hippocampal CA1 sector: an immunohistochemical study. Metab. Brain Dis. 2008, 23(4):399-409.
44. Song G.Y., Kang J.S., Lee S.Y., Myung C.S. Region-specific reduction of Gbeta4 expression and induction of the phosphorylation of PKB/Akt and ERK1/2 by aging in rat brain. Pharmacol. Res. 2007, 56(4):295-302.
45. García-San Frutos M., Fernández-Agulló T., De Solís A.I., Andrés A., Arribas C., Carrascosa J.M., Ros M. Impaired central insulin response in aged Wistar rats: role of adiposity. Endocrinology 2007, 148(11):5238-5247.
46. Parekh V.V., Falcone J.C., Wills-Frank L.A., Joshua I.G., Dholakia J.N., Passmore J.C. Protein kinase B, P34cdc2 kinase, and p21 ras GTP-binding in kidneys of aging rats. Exp. Biol. Med. (Maywood) 2004, 229(8):850-856.
47. Watanabe H., Saito H., Rychahou P.G., Uchida T., Evers B.M. Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation. Gastroenterology 2005, 128(5):1391-1404.
48. Ikeyama S., Kokkonen G., Shack S., Wang X.T., Holbrook N.J. Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities. FASEB J. 2002, 16(1):114-116.
49. Gupte A.A., Bomhoff G.L., Geiger P.C. Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J. Appl. Physiol. 2008, 105(3):839-848.
50. Miyauchi H., Minamino T., Tateno K., Kunieda T., Toko H., Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004, 23(1):212-220.
51. Veiga S., Garcia-Segura L.M., Azcoitia I. Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzime aromatase. J. Neurobiol. 2003, 56:398-406.
52. Hajszan T., Maclusky N.J., Leranth C. Dehydroepiandrosterone increases hippocampal spine synapse density in ovariectomized female rats. Endocrinology 2004, 145(1042):1045.
53. Garcia-Segura L.M., Sanz A., Mendez P. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 2006, 84(4):275-279.
54. Cardona-Gomez G.P., Mendez P., Garcia-Segura L.M. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Mol. Brain Res. 2002, 107(1):80-88.
55. Li S., Givalois L., Pelletier G. Dehydroepiandrosterone (DHEA) administration reverses the inhibitory influence of aging on gonadotrophin-releasing hormone gene expression in the male and female rat brain. Endocrine 1997, 6:265-270.
56. Givalois L., Li S., Pelletier G. Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in male and female rats. Mol. Brain Res. 1997, 48:107-114.
57. Iruthayanathan M., Zhou Y.H., Childs G.V. Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors. Endocrinology 2005, 146(12):5176-5187.
58. Horwood J.M., Dufour F., Laroche S., Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur. J. Neurosci. 2006, 23(12):3375-3384.
59. Yefet K., Merhav M., Kuulmann-Vander S., Elkobi A., Belelovsky K., Jacobson-Pick S., Meiri N., Rosenblum K. Different signal transduction cascades are activated simultaneously in the rat insular cortex and hippocampus following novel taste learning. Eur. J. Neurosci. 2006, 24(5):1434-1442.
60. Formoso G., Chen H., Kim J., Montagnani M., Consoli A., Quon M.I. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase- dependent pathways in vascular endothelium. Mol. Endocrinol. 2006, 20(5):1153-1163.
61. Liu D., Si H., Reynolds K.A., Zhen W., Jia Z., Dillon J.S. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a G Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 2007, 148(7):3068-3076.
62. Lin S-Y.J., Cui H., Yusta B., Belsham D.D. IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neurons. Mol. Cell. Endocrinol. 2004, 214:127-135.